ReviewJournal of the American Heart Association2026
Structural and Functional Abnormalities in the Preterm Heart: From Development to Adulthood.
Review in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preterm infants with structurally normal hearts have a higher risk of developing cardiovascular disease in adulthood when compared with term infants with structurally normal hearts. A milieu of factors are implicated in these patients' cardiovascular morbidity and mortality: supraphysiologic/subphysiologic exposure to oxygen, disrupted cellular architecture, changes in extracellular matrix composition, abnormal cardiomyocyte mitochondria number and function, immature sarcoplasmic/endoplasmic reticulum, and increased exposure to surgical procedural stress (among other mechanisms to be reviewed herein). Heightened cardiovascular risk merits clinical surveillance. Current technologies, like blood pressure monitoring, lipid panel testing, echocardiography, and cardiac magnetic resonance imaging, can identify abnormalities in these patients. Best practice guidelines vary on the identification of premature birth as a significant risk factor for cardiovascular morbidity and mortality that should impact patient management. Obesity in these patients may confer heightened risk, and merits further study. Education on cardiovascular risk reduction should be standard of care when counseling the family of a child with a history of prematurity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.